RU2015144359A3 - - Google Patents

Download PDF

Info

Publication number
RU2015144359A3
RU2015144359A3 RU2015144359A RU2015144359A RU2015144359A3 RU 2015144359 A3 RU2015144359 A3 RU 2015144359A3 RU 2015144359 A RU2015144359 A RU 2015144359A RU 2015144359 A RU2015144359 A RU 2015144359A RU 2015144359 A3 RU2015144359 A3 RU 2015144359A3
Authority
RU
Russia
Application number
RU2015144359A
Other languages
Russian (ru)
Other versions
RU2662665C2 (ru
RU2015144359A (ru
Filing date
Publication date
Priority claimed from US13/843,289 external-priority patent/US20140274915A1/en
Application filed filed Critical
Publication of RU2015144359A publication Critical patent/RU2015144359A/ru
Publication of RU2015144359A3 publication Critical patent/RU2015144359A3/ru
Application granted granted Critical
Publication of RU2662665C2 publication Critical patent/RU2662665C2/ru

Links

RU2015144359A 2013-03-15 2014-03-16 Улучшенные способы применения рекомбинантных секретоглобинов человека RU2662665C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/843,289 US20140274915A1 (en) 2013-03-15 2013-03-15 Methods of Use for Recombinant Human Secretoglobins
US13/843,289 2013-03-15
PCT/US2014/030101 WO2014145357A2 (en) 2013-03-15 2014-03-16 Improved methods of use for recombinant human secretoglobins

Publications (3)

Publication Number Publication Date
RU2015144359A RU2015144359A (ru) 2017-04-25
RU2015144359A3 true RU2015144359A3 (enExample) 2018-02-13
RU2662665C2 RU2662665C2 (ru) 2018-07-26

Family

ID=51529893

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015144359A RU2662665C2 (ru) 2013-03-15 2014-03-16 Улучшенные способы применения рекомбинантных секретоглобинов человека

Country Status (15)

Country Link
US (5) US20140274915A1 (enExample)
EP (1) EP2968464B1 (enExample)
JP (1) JP6513632B2 (enExample)
KR (1) KR20160011621A (enExample)
CN (1) CN105722524B (enExample)
AU (1) AU2014233116A1 (enExample)
BR (1) BR112015021265A2 (enExample)
CA (1) CA2907395A1 (enExample)
ES (1) ES2883933T3 (enExample)
IL (1) IL241418A0 (enExample)
MX (1) MX2015013091A (enExample)
RU (1) RU2662665C2 (enExample)
SG (1) SG11201507276UA (enExample)
UA (1) UA118756C2 (enExample)
WO (1) WO2014145357A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140274915A1 (en) * 2013-03-15 2014-09-18 Clarassance, Inc. Methods of Use for Recombinant Human Secretoglobins
WO2016205430A1 (en) * 2015-06-15 2016-12-22 Therabron Therapeutics, Inc. Recombinant human cc10 protein facilitates repair and protects against damage to the respiratory epithelium due to exposure to both cigarette and other smoke
WO2018178051A1 (en) * 2017-03-28 2018-10-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction
WO2019143934A1 (en) 2018-01-19 2019-07-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-cancer activity of scbg3a2 and lps
EP3886900A4 (en) * 2018-11-30 2022-08-31 APC Research Assets LLC COMPOSITIONS AND METHODS OF USE FOR SECRETOGLOBINS FOR GLYCOCALYX PROTECTION THROUGH INTERACTIONS WITH HEPARAN SULFATE PROTEOGLYCAN PROTEINS
KR20200138684A (ko) * 2020-11-17 2020-12-10 김유신 토양 파쇄기를 장착한 친환경 고온스팀 토양소독기
WO2023212398A1 (en) * 2022-04-29 2023-11-02 Apc Research Assets Llc Secretoglobins for suppression of antibody responses
CN119631983B (zh) * 2024-12-30 2025-07-22 西南医科大学 一种心脏原发性肿瘤小鼠模型的构建方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040047857A1 (en) 1997-05-28 2004-03-11 Pilon Aprile L. Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20030008816A1 (en) 1997-05-28 2003-01-09 Pilon Aprile L. Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
AU5551299A (en) 1998-08-13 2000-03-06 Trustees Of The University Of Pennsylvania, The Method of identifying proteins
US6953666B1 (en) 1998-11-06 2005-10-11 Emory University Biomarkers for oxidative stress
WO2004101824A1 (ja) * 2003-05-14 2004-11-25 Shionogi & Co., Ltd. 慢性閉塞性肺疾患の検出方法
AU2004254600A1 (en) * 2003-06-26 2005-01-13 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
TW200526251A (en) 2003-11-14 2005-08-16 Alza Corp Minimization of drug oxidation in drug irradiated excipients formulations
US20060275794A1 (en) * 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
JP2007059191A (ja) 2005-08-24 2007-03-08 Kazuo Kono 照明器具駆動回路
US8133859B2 (en) * 2006-09-27 2012-03-13 The United States Of America As Represented By The Department Of Health And Human Services SCGB3A2 as a growth factor and anti-apoptotic agent
US20090004684A1 (en) 2007-05-23 2009-01-01 Claudia Susanne Maier Compositions and Methods for Detection and Quantification of Protein Oxidation
WO2011047065A1 (en) 2009-10-15 2011-04-21 Clarassance, Inc. Recombinant human cc10 protein for treatment of influenza
RU2439569C1 (ru) * 2010-11-12 2012-01-10 Федеральное государственное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования бронхолегочной дисплазии у детей с врожденной пневмонией
US20140274915A1 (en) * 2013-03-15 2014-09-18 Clarassance, Inc. Methods of Use for Recombinant Human Secretoglobins

Similar Documents

Publication Publication Date Title
BR112021000792B8 (enExample)
AT524834A2 (enExample)
AU2018438767B1 (enExample)
AT521543A3 (enExample)
AT524961A5 (enExample)
AT524266A2 (enExample)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112020016338B1 (pt) Dispositivo para tratamento de tecido corporal
BR112021001434B1 (pt) Aço com alto teor de manganês e método de produção do mesmo
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020026077B1 (pt) Recipiente com estrutura encaixável
BR112020026721B1 (pt) Aparelho de moldagem para modar uma folha de um material contendo alcaloides
BR102019012845B1 (pt) Montagens de guia de entrada de piso de compartimento de carga retráteis para carregamentos paletizados em aeronaves de carga e aeronave e carga
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020024987B1 (pt) Método, montagem e sistema para prover uma estrutura de base, método industrial, e, braço mecânico
BR112020023823B1 (pt) Distribuidor
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas
BR112020020812B1 (pt) Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado
BR112020015757B1 (pt) Métodos, sistema, kit e dispositivos para visualização e remoção de tumor
BR102019000241B1 (pt) Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados